Regeneron Pharmaceuticals, Inc.

Holdings as of Jun 30, 2026 · filed Aug 7, 2026

$177219142
Portfolio value
3
Positions
Source: SEC 13-F ↗
Original filing
# Holding Value % Port. Δ Shares Change (QoQ)
1 Parabilis Medicines, Inc. $114041648 64.35% NEW BUY
2 Intellia Therapeutics, Inc. $62654675 35.35% Held
3 Adicet Bio, Inc. $522819 0.30% NEW BUY

Closed last quarter

Adicet Bio, Inc.

Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.